Stuttering Treatment Market is driven by increasing prevalence of neurodevelopmental disorders
The stuttering treatment market consists of various speech therapies and medications that help reduce stuttering and improve speech fluency. Stuttering, also known as stammering, is a speech disorder characterized by repetitions, prolongations of sounds, syllables or words as well as interruptions in the fluency of speech. It is estimated that around 70 million people across the world have a stuttering disorder with the condition more prevalent in males than females.
The Global Stuttering Market is estimated to be valued at USD 51.5 million in 2024 and is expected to reach USD 150.1 million by 2031, growing at a compound annual growth rate (CAGR) of 11.3% from 2024 to 2031.
The global Stuttering Market is growing due to increasing prevalence of neurodevelopmental and communicative disorders leading to stuttering. According to WHO, over 70 million people globally have a stuttering or stammering disorder with higher prevalence between ages of 2 to 5 years. Rising awareness about available treatment options and programs, support groups as well as presence of government policies providing speech therapy coverage are driving demand for stuttering treatment solutions.
Get More Insights On- Stuttering Market
Get this Report in Japanese Language: 吃音治療市場
Get this Report in Korean Language: 말더듬증 치료 시장
Explore More Related Articles- Advancing Global Remote Sensing Services
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian